Philadelphia-based Impilo, which develops vital infrastructure to enable digital delivery of healthcare, has closed a $11.5 million Series A round, led by Washington, D.C.-based Construct Capital. GC 1 Capital, Boston-based One Way Ventures, Princeton, N.J.-based 2048 Ventures, and other angel investors also participated.
Founded in 2020, Impilo’s technologies allows healthcare providers deliver diagnostic services and care to patients in the comfort of their homes, and also remotely monitor their health via remote sensors and other devices. Its services hinge on so-called 4PL — an operational model in which a business outsources its entire supply chain management and logistics to one external service provider.
Focus on Remote Care
“This funding is a game-changer for us,” said Impilo founder and CEO Josh Stein. “It will allow us to supercharge our growth, expand our footprint across the provider and payer sectors, and continue to innovate on a platform that makes high-quality healthcare more accessible than ever.”
Commercial Real Estate
MacKenzie Companies
Advertising / Media / Communications / Public Relations
Nevins & Associates
Financial Services / Investment Firms
Chesapeake Corporate Advisors
Commercial Real Estate
Monday Properties
Venture Capital
Blue Delta Capital Partners
Internet / Technology
Foxtrot Media
Stein, who earned his B.S. degree in Mechanical Engineering from the University of Maryland, previously founded Loop Health. He earned an MBA from New York’s Cornell Tech. Impilo plans to use the new funding to enhance its technology infrastructure and additionally launch new at-home offerings.
‘Reimagining Future’
Impilo is a perfect example of companies that are “reimagining the future of industries,” said Dayna Grayson, general partner at Construct Capital. Its “groundbreaking approach to integrating logistics, data, and real-time patient monitoring will reshape the future of at-home care — and we’re honored to partner with them to bring this transformative vision to life,” added Grayson.
Alex Iskold, general partner at 2048 Ventures, said his firm has “long believed that real-time, at-home patient monitoring is the future.” Impilo is building the foundational infrastructure to make that vision a reality, he added. The N.J. venture firm was Impilo’s first investor.
